Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients

被引：84

作者：

Williams, Jennifer ^{[1
]}

Sayles, Harlan R. ^{[2
]}

Meza, Jane L. ^{[2
]}

Sayre, Patrick ^{[3
]}

Sandkovsky, Uriel ^{[1
]}

Gendelman, Howard E. ^{[1
,4
]}

Flexner, Charles ^{[3
]}

Swindells, Susan ^{[1
]}

机构：

[1] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA

[2] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE 68198 USA

[3] Johns Hopkins Univ, Div Clin Pharmacol, Baltimore, MD 21287 USA

[4] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA

来源：

NANOMEDICINE | 2013年 / 8卷 / 11期

关键词：

AIDS; antiretroviral therapy; HIV; intravenous drug abuse; nanoformulated antiretroviral therapy; nonadherence; substance abuse; DRUG-RESISTANCE; NANOMEDICINE; ADHERENCE; MICE;

D O I：

10.2217/nnm.12.214

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To gauge patient interest in receiving long-acting injectable nanoformulated antiretroviral therapy. Methods: Four hundred adult HIV-infected patients currently prescribed antiretroviral therapy were surveyed. (2) tests were used for comparisons of interest across groups. Results: Respondents were 68% male and 53% African-American, with a mean age of 47 years. Overall, 73% of patients indicated that they would definitely or probably try injectable nanoformulated antiretroviral therapy; 61% with weekly dosing; 72% every 2 weekly; and 84% monthly. In total, 48% indicated that they were very concerned about the possible side effects and 35% were very concerned about needle use. Conclusion: The majority of respondents indicated that they definitely or probably would try parenteral nanoformulated antiretroviral therapy. Original submitted 24 May 2012; Revised submitted 2 November 2012; Published online 23 April 2013

引用

页码：1807 / 1813

页数：7

共 50 条

[1] Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice
Dash, Prasanta K.
Gendelman, Howard E.
Roy, Upal
Balkundi, Shantanu
Alnouti, Yazen
Mosley, Rodney L.
Gelbard, Harris A.
McMillan, JoEllyn
Gorantla, Santhi
Poluektova, Larisa Y.
[J]. AIDS, 2012, 26 (17) : 2135 - 2144
[2] Cell-Targeted Long-Acting Nanoformulated Antiretroviral Therapy
Puligujja, Pavan
Veerubhotla, Ram
McMillan, JoEllyn
Gendelman, Howard
Liu, Xinming
[J]. JOURNAL OF NEUROVIROLOGY, 2012, 18 : 88 - 88
[3] Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy
Gautam, Nagsen
Roy, Upal
Balkundi, Shantanu
Puligujja, Pavan
Guo, Dongwei
Smith, Nathan
Liu, Xin-Ming
Lamberty, Benjamin
Morsey, Brenda
Fox, Howard S.
McMillan, JoEllyn
Gendelman, Howard E.
Alnouti, Yazen
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 3110 - 3120
[4] Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders
Gendelman, Howard E.
Gelbard, Harris A.
[J]. CURRENT OPINION IN HIV AND AIDS, 2014, 9 (06) : 585 - 590
[5] Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
Mariluz Araínga
Dongwei Guo
Jayme Wiederin
Pawel Ciborowski
JoEllyn McMillan
Howard E Gendelman
[J]. Retrovirology, 12
[6] Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
Arainga, Mariluz
Guo, Dongwei
Wiederin, Jayme
Ciborowski, Pawel
McMillan, JoEllyn
Gendelman, Howard E.
[J]. RETROVIROLOGY, 2015, 12
[7] Antiretroviral therapy of HIV-infected patients
Gölz, J
[J]. MEDIZINISCHE WELT, 1999, 50 (06): : 223 - 229
[8] Long-acting antiretroviral therapy
Soriano, Vicente
Barreiro, Pablo
de Mendoza, Carmen
[J]. NATURE MATERIALS, 2020, 19 (08) : 826 - 827
[9] Long-acting antiretroviral therapy
Vicente Soriano
Pablo Barreiro
Carmen de Mendoza
[J]. Nature Materials, 2020, 19 : 826 - 827
[10] ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS - UPDATE
BARTLETT, JG
[J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1994, 3 (05) : 340 - 344

← 1 2 3 4 5 →